Table 1.

The relationship between expression of lncRNA-D16366 and clinicopathological characteristics.

Clinicopathological characteristics	n	lncRNA-D16366 expression		P
		High	Low
Age				0.762
40–50	25	12	13
51–60	47	24	23
61–70	35	15	20
Sex				0.164
Female	45	25	20
Male	62	26	36
Tumor size				0.000
<3 cm	43	34	9
3–5 cm	33	13	20
5–10 cm	24	2	22
>10 cm	7	2	5
Tumor site				0.282
Left	49	27	22
Right	43	19	24
Both	15	5	10
HbsAg				0.005
No	50	31	19
Yes	57	20	37
AFP				0.783
<20 ng/mL	41	20	21
20–400 ng/mL	34	17	17
>400–1000 ng/mL	21	8	13
>1000 ng/mL	11	6	5
Portal vein tumor thrombus				0.001
No	42	12	30
Yes	65	39	26
Child-Pugh				0.033
A	9	8	1
B	62	28	34
C	36	15	21
Therapies				0.003
TACE	35	9	26
Conservative treatment	32	16	16
Combined therapy	40	26	14
Neoplasm metastasis				0.000
No	40	28	12
Yes	67	23	44